|
1
|
Saidi RF and Kenari SK: Liver
ischemia/reperfusion injury: An overview. J Invest Surg. 6:366–379.
2014.PubMed/NCBI View Article : Google Scholar
|
|
2
|
van Golen RF, Reiniers MJ, Olthof PB, van
Gulik TM and Heger M: Sterile inflammation in hepatic
ischemia/reperfusion injury: Present concepts and potential
therapeutics. J Gastroenterol Hepatol. 3:394–400. 2013.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Quesnelle KM, Bystrom PV and
Toledo-Pereyra LH: Molecular responses to ischemia and reperfusion
in the liver. Arch Toxicol. 5:651–657. 2015.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Wang Y, Liu ZS, Zhang SL, Diao QX and Ge
YJ: Effect and mechanism of portal blood stasis removal on
intestinal endotoxemia and hepatic ischemia reperfusion injury.
Transplant Proc. 9:2752–2756. 2015.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Huang H, Tohme S, Al-Khafaji AB, Tai S,
Loughran P, Chen L, Wang S, Kim J, Billiar T, Wang Y and Tsung A:
Damage-associated molecular pattern-activated neutrophil
extracellular trap exacerbates sterile inflammatory liver injury.
Hepatology. 2:600–614. 2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Xu L, Ge F, Hu Y, Yu Y, Guo K and Miao C:
Sevoflurane postconditioning attenuates hepatic
ischemia-reperfusion injury by limiting HMGB1/TLR4/NF-kappaB
pathway via modulating microRNA-142 in vivo and in vitro. Front
Pharmacol. 12(646307)2021.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Tsung A, Sahai R, Tanaka H, Nakao A, Fink
MP, Lotze MT, Yang H, Li J, Tracey KJ, Geller DA and Billiar TR:
The nuclear factor HMGB1 mediates hepatic injury after murine liver
ischemia-reperfusion. J Exp Med. 7:1135–1143. 2005.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Perretti M and D'Acquisto F: Annexin A1
and glucocorticoids as effectors of the resolution of inflammation.
Nat Rev Immunol. 1:62–70. 2009.PubMed/NCBI View
Article : Google Scholar
|
|
9
|
Yang YH, Morand E and Leech M: Annexin A1:
Potential for glucocorticoid sparing in RA. Nat Rev Rheumatol.
10:595–603. 2013.PubMed/NCBI View Article : Google Scholar
|
|
10
|
La M, D'Amico M, Bandiera S, Di Filippo C,
Oliani SM, Gavins FN, Flower RJ and Perretti M: Annexin 1 peptides
protect against experimental myocardial ischemia-reperfusion:
Analysis of their mechanism of action. FASEB J. 12:2247–2256.
2001.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Guido BC, Zanatelli M, Tavares-De-Lima W,
Oliani SM and Damazo AS: Annexin-A1 peptide down-regulates the
leukocyte recruitment and up-regulates interleukin-10 release into
lung after intestinal ischemia-reperfusion in mice. J Inflamm
(Lond). 1(10)2013.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Perretti M and Flower RJ: Annexin 1 and
the biology of the neutrophil. J Leukoc Biol. 1:25–29.
2004.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Facio FJ, Sena AA, Araujo LP, Mendes GE,
Castro I, Luz MA, Yu L, Oliani SM and Burdmann EA: Annexin 1
mimetic peptide protects against renal ischemia/reperfusion injury
in rats. J Mol Med (Berl). 1:51–63. 2011.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Care NRCU, Animals AUOL: Guide for the
care and use of laboratory animals. Washington (DC): National
Academies Press (US), 2011.
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 4:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Wang J, Yu S, Li J, Li H, Jiang H, Xiao P,
Pan Y, Zheng J, Yu L and Jiang J: Protective role of
N-acetyl-l-tryptophan against hepatic ischemia-reperfusion injury
via the RIP2/caspase-1/IL-1β signaling pathway. Pharm Biol.
1:385–391. 2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Datta G, Fuller BJ and Davidson BR:
Molecular mechanisms of liver ischemia reperfusion injury: Insights
from transgenic knockout models. World J Gastroenterol.
11:1683–1698. 2013.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Cirino G, Cicala C, Sorrentino L,
Ciliberto G, Arpaia G, Perretti M and Flower RJ: Anti-inflammatory
actions of an N-terminal peptide from human lipocortin 1. Br J
Pharmacol. 3:573–574. 1993.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Perretti M and Flower RJ: Modulation of
IL-1-induced neutrophil migration by dexamethasone and lipocortin
1. J Immunol. 3:992–999. 1993.PubMed/NCBI
|
|
20
|
Perretti M, Ahluwalia A, Harris JG,
Goulding NJ and Flower RJ: Lipocortin-1 fragments inhibit
neutrophil accumulation and neutrophil-dependent edema in the
mouse. A qualitative comparison with an anti-CD11b monoclonal
antibody. J Immunol. 8:4306–4314. 1993.PubMed/NCBI
|
|
21
|
Kamaly N, Fredman G, Subramanian M, Gadde
S, Pesic A, Cheung L, Fayad ZA, Langer R, Tabas I and Farokhzad OC:
Development and in vivo efficacy of targeted polymeric
inflammation-resolving nanoparticles. Proc Natl Acad Sci USA.
16:6506–6511. 2013.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Gavins FN, Dalli J, Flower RJ, Granger DN
and Perretti M: Activation of the annexin 1 counter-regulatory
circuit affords protection in the mouse brain microcirculation.
FASEB J. 8:1751–1758. 2007.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Wang J, He GZ, Wang YK, Zhu QK, Chen W and
Guo T: TLR4-HMGB1-, MyD88- and TRIF-dependent signaling in mouse
intestinal ischemia/reperfusion injury. World J Gastroenterol.
27:8314–8325. 2015.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Xue J, Ge H, Lin Z, Wang H, Lin W, Liu Y,
Wu G, Xia J and Zhao Q: The role of dendritic cells regulated by
HMGB1/TLR4 signalling pathway in myocardial ischaemia reperfusion
injury. J Cell Mol Med. 4:2849–2862. 2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Tsaroucha AK, Valsami G, Kostomitsopoulos
N, Lambropoulou M, Anagnostopoulos C, Christodoulou E, Falidas E,
Betsou A, Pitiakoudis M and Simopoulos CE: Silibinin effect on
Fas/FasL, HMGB1, and CD45 expressions in a rat model subjected to
liver ischemia-reperfusion injury. J Invest Surg. 6:491–502.
2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Sugihara M, Sadamori H, Nishibori M, Sato
Y, Tazawa H, Shinoura S, Umeda Y, Yoshida R, Nobuoka D, Utsumi M,
et al: Anti-high mobility group box 1 monoclonal antibody improves
ischemia/reperfusion injury and mode of liver regeneration after
partial hepatectomy. Am J Surg. 1:179–188. 2016.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Mcdonald KA, Huang H, Tohme S, Loughran P,
Ferrero K, Billiar T and Tsung A: Toll-like receptor 4 (TLR4)
antagonist eritoran tetrasodium attenuates liver ischemia and
reperfusion injury through inhibition of high-mobility group box
protein B1 (HMGB1) signaling. Mol Med. 20:639–648. 2015.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Nace GW, Huang H, Klune JR, Eid RE,
Rosborough BR, Korff S, Li S, Shapiro RA, Stolz DB, Sodhi CP, et
al: Cellular-specific role of toll-like receptor 4 in hepatic
ischemia-reperfusion injury in mice. Hepatology. 1:374–387.
2013.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Zhu JR, Lu HD, Guo C, Fang WR, Zhao HD,
Zhou JS, Wang F, Zhao YL, Li YM, Zhang YD, et al: Berberine
attenuates ischemia-reperfusion injury through inhibiting HMGB1
release and NF-kappaB nuclear translocation. Acta Pharmacol Sin.
11:1706–1715. 2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Zhang S, Feng Z, Gao W, Duan Y, Fan G,
Geng X, Wu B, Li K, Liu K and Peng C: Aucubin attenuates liver
ischemia-reperfusion injury by inhibiting the HMGB1/TLR-4/NF-kappaB
signaling pathway, oxidative stress, and apoptosis. Front
Pharmacol. 11(544124)2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Leoni G, Neumann PA, Kamaly N, Quiros M,
Nishio H, Jones HR, Sumagin R, Hilgarth RS, Alam A, Fredman G, et
al: Annexin A1-containing extracellular vesicles and polymeric
nanoparticles promote epithelial wound repair. J Clin Invest.
3:1215–1227. 2015.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Reischl S, Lee JH, Miltschitzky J,
Vieregge V, Walter RL, Twardy V, Kasajima A, Friess H, Kamaly N and
Neumann PA: Ac2-26-nanoparticles induce resolution of intestinal
inflammation and anastomotic healing via inhibition of NF-κB
signaling in a model of perioperative colitis. Inflamm Bowel Dis.
9:1379–1393. 2021.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Tsung A, Klune JR, Zhang X, Jeyabalan G,
Cao Z, Peng X, Stolz DB, Geller DA, Rosengart MR and Billiar TR:
HMGB1 release induced by liver ischemia involves Toll-like receptor
4 dependent reactive oxygen species production and calcium-mediated
signaling. J Exp Med. 12:2913–2923. 2007.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Baxter GF: The neutrophil as a mediator of
myocardial ischemia-reperfusion injury: Time to move on. Basic Res
Cardiol. 4:268–275. 2002.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Vinten-Johansen J: Involvement of
neutrophils in the pathogenesis of lethal myocardial reperfusion
injury. Cardiovasc Res. 3:481–497. 2004.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Yago T, Petrich BG, Zhang N, Liu Z, Shao
B, Ginsberg MH and Mcever RP: Blocking neutrophil integrin
activation prevents ischemia-reperfusion injury. J Exp Med.
8:1267–1281. 2015.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Jaeschke H, Farhood A and Smith CW:
Neutrophil-induced liver cell injury in endotoxin shock is a
CD11b/CD18-dependent mechanism. Am J Physiol. 261 (6 Pt
1):G1051–G1056. 1991.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Hoffman JJ, Gilbert TB, Poston RS and
Silldorff EP: Myocardial reperfusion injury: Etiology, mechanisms,
and therapies. J Extra Corpor Technol. 4:391–411. 2004.PubMed/NCBI
|
|
39
|
Saiman Y and Friedman SL: The role of
chemokines in acute liver injury. Front Physiol.
3(213)2012.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Monson KM, Dowlatshahi S and Crockett ET:
CXC-chemokine regulation and neutrophil trafficking in hepatic
ischemia-reperfusion injury in P-selectin/ICAM-1 deficient mice. J
Inflamm (Lond). 4(11)2007.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Perry BC, Soltys D, Toledo AH and
Toledo-Pereyra LH: Tumor necrosis factor-α in liver
ischemia/reperfusion injury. J Invest Surg. 4:178–188.
2011.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Uchida Y, Freitas MC, Zhao D, Busuttil RW
and Kupiec-Weglinski JW: The inhibition of neutrophil elastase
ameliorates mouse liver damage due to ischemia and reperfusion.
Liver Transpl. 8:939–947. 2009.PubMed/NCBI View Article : Google Scholar
|
